Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gender-specific differences in depression and treatment response.

Susan G Kornstein1, Diane M E Sloan, Michael E Thase

  • 1Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, USA.

Psychopharmacology Bulletin
|July 15, 2003
PubMed
Summary

Women experience depression at twice the rate of men, with significant gender differences in symptoms, course, and treatment response. Understanding these disparities is crucial for effective depression care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Could Treatment Matching Patients' Beliefs About Depression Improve Outcomes?

Behavior therapy·2019
Same author

The Role of Dyadic Discord in Outcomes in Acute Phase Cognitive Therapy for Adults With Recurrent Major Depressive Disorder.

Behavior therapy·2019
Same author

Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials.

Acta neuropsychiatrica·2019
Same author

Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.

JAMA psychiatry·2019
Same author

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.

The American journal of psychiatry·2019
Same author

Response to: Goldberg et al. and Severance et al. Letters to the Editor: The clinical significance of improving remission over standard of care - The reality of treatment resistant-based therapies.

Journal of psychiatric research·2019

Area of Science:

  • Psychiatry
  • Neuroscience
  • Epidemiology

Background:

  • Depression prevalence is approximately twice as high in women compared to men.
  • Both neurobiological and psychosocial factors are implicated in this gender disparity.
  • Gender influences depression's symptom presentation, comorbidities, illness course, and treatment outcomes.

Purpose of the Study:

  • To provide an overview of gender differences in the phenomenology of depression.
  • To examine the impact of gender on antidepressant treatment response.
  • To highlight the importance of considering gender in depression assessment and management.

Main Methods:

  • Review of epidemiologic studies on depression prevalence and gender.
  • Analysis of literature on gender-specific symptom presentation and illness course.

Related Experiment Videos

  • Synthesis of research on gender differences in antidepressant efficacy and tolerability.

    • Main Results:

    • Women exhibit distinct patterns in depression symptomatology and comorbidity.
    • Gender influences the trajectory and long-term course of depressive disorders.
    • Antidepressant treatment response can vary significantly between genders, necessitating personalized approaches.

    Conclusions:

    • Gender is a critical factor influencing the manifestation and progression of depression.
    • Tailoring depression assessment and treatment strategies to gender is essential for optimizing patient outcomes.
    • Further research is warranted to elucidate the mechanisms underlying gender differences in depression and its treatment.